Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatmen

• Status: Unknown status
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh) agonist to prevent the rise of progesterone during controlled ovarian stimulation for in vitro fertilization (IVF) after the administration of human Chorionic Gonadotropin (hCG) on the first day of menses.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo
• Treatments: Chorionic Gonadotropin; Deslorelin; Goserelin; Hormones; Luteolytic Agents; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• age >21 and < 38 years old

• polycystic ovarian syndrome

• risk for ovarian hyperstimulation syndrome

Exclusion Criteria:

• recurrent abortion

• endometriosis

• more than 3 IVF failures

• use of oral contraceptive pills in the preceding 3 months

• low response to gonadotropins